Status:
UNKNOWN
Observation of Cough Variant Asthma Treated in Combination of Chanqin Granules.
Lead Sponsor:
Shanghai University of Traditional Chinese Medicine
Conditions:
Cough Variant Asthma
Eligibility:
All Genders
18-70 years
Phase:
PHASE1
PHASE2
Brief Summary
This single-center, randomized, double-blind, placebo-controlled trial was undertaken at an outpatient clinic in Shuguang Hospital. Newly diagnosed cough variant asthma adult patients with the T.C.M. ...
Detailed Description
This single-center, randomized, double-blind, placebo-controlled trial was undertaken at an outpatient clinic in Shuguang Hospital. Newly diagnosed cough variant asthma adult patients with the T.C.M. ...
Eligibility Criteria
Inclusion
- Diagnosis of cough variant asthma according to Western medicine
- Diagnosis of cough with pathogenic wind syndrome according to TCM
- Aged between 18 to 70 years, regardless of gender, race or educational and economic status
- The cough symptom should last for at least 8 weeks
- 4\. Willingness to participate and to sign the informed consent form
Exclusion
- Patients with history of smoking (or quite smoking for less than 6 months)
- Systemic use of corticosteroids in the past 4 weeks
- Upper or lower respiratory tract infection in the past 4 weeks
- Incapable of corporation with spirometry and FeNO test
- Other chronic respiratory disease eg: COPD, pulmonary cirrhosis
- Women who are pregnant or preparing to become pregnant or breast feeding women
Key Trial Info
Start Date :
November 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2019
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT03319043
Start Date
November 1 2017
End Date
June 30 2019
Last Update
October 24 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine
Shanghai, Shanghai Municipality, China, 201203